Sfoglia per Rivista UROLOGIC ONCOLOGY
Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection
2014-01-01 Passoni, Nm; Abdollah, F; Suardi, N; Gallina, A; Bianchi, M; Tutolo, M; Fossati, N; Gandaglia, G; Salonia, A; Freschi, M; Rigatti, P; Montorsi, F; Briganti, A
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder
2019-01-01 Palumbo, C.; Mistretta, F. A.; Knipper, S.; Pecoraro, A.; Tian, Z.; Shariat, S. F.; Saad, F.; Simeone, C.; Briganti, A.; Antonelli, A.; Karakiewicz, P. I.
Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study
2021-01-01 Gontero, P.; Mari, A.; Marra, G.; Nazzani, S.; Allasia, M.; Antonelli, A.; Barale, M.; Brunocilla, E.; Capitanio, U.; Di Maida, F.; Gallioli, A.; Longo, N.; Montorsi, F.; Porpiglia, F.; Porreca, A.; Rocco, B.; Simeone, C.; Schiavina, R.; Tellini, R.; Terrone, C.; Villari, D.; Ficarra, V.; Carini, M.; Minervini, A.
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses
2015-01-01 Larcher, A; Fossati, N; Mistretta, F; Lughezzani, G; Lista, G; Dell'Oglio, P; Abrate, A; Sun, M; Karakiewicz, P; Suardi, N; Lazzeri, M; Montorsi, F; Guazzoni, G; Buffi, N
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up
2005-01-01 Berruti, Alfredo; Fara, E; Tucci, M; Tarabuzzi, R; Mosca, A; Terrone, C; Gorzegno, G; Fasolis, G; Tampellini, M; Porpiglia, F; DE STEFANIS, M; Fontana, D; Bertetto, O; Dogliotti, L.
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study.
2012-01-01 A., Antonelli; N., Arrighi; S., Corti; T., Zanotelli; A., Cozzoli; S. C., Cunico; Simeone, Claudio
Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification
2013-01-01 Abdollah, F; Sun, M; Suardi, N; Gallina, A; Capitanio, U; Bianchi, M; Tutolo, M; Fossati, N; Castiglione, F; Freschi, M; Karakiewicz, P; Rigatti, P; Montorsi, F; Briganti, A
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.
2013-01-01 Saini, A; Berruti, Alfredo; Cracco, C; Sguazzotti, E; Porpiglia, F; Russo, L; Bertaglia, V; Picci, Rl; Negro, M; Tosco, A; Campagna, S; Scarpa, Rm; Dogliotti, L; Furlan, Pm; Ostacoli, L.
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer.
2013-01-01 Vigna-Taglianti, R; Russi, Eg; Boriano, A; Gianello, L; Denaro, N; Lucio, F; Arena, G; e Bastia M, Buglione Di Monale; Pergolizzi, S; Ricardi, U; Magrini, S.
The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: Conditional survival analysis
2014-01-01 Abdollah, F; Suardi, N; Capitanio, U; Matloob, R; Fossati, N; Castiglione, F; Di Trapani, E; Di Trapani, D; Russo, A; Carenzi, C; Montorsi, F; Rigatti, P; Bertini, R
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset
2020-01-01 Veccia, A.; Antonelli, A.; Minervini, A.; Mottrie, A.; Dell'Oglio, P.; Ashrafi, A. N.; Larcher, A.; Eun, D.; Bradshaw, A.; Amparore, D.; Brassetti, A.; Hampton, L. J.; Simeone, C.; Mari, A.; Carini, M.; De Naeyer, G.; Yang, K.; Capitanio, U.; Simone, G.; Porpiglia, F.; Derweesh, I.; Aron, M.; Autorino, R.
Utility of [C-11]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series
2014-01-01 Passoni, Nm; Suardi, N; Abdollah, F; Picchio, M; Giovacchini, G; Messa, C; Freschi, M; Montorsi, F; Briganti, A
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series
2015-01-01 Gandaglia, G; Ploussard, G; Isbarn, H; Suardi, N; De Visschere, Pjl; Futterer, Jj; Ghadjar, P; Massard, C; Ost, P; Sooriakumaran, P; Surcel, Ci; van den Bergh, Rcn; Montorsi, F; Ficarra, V; Giannarini, G; Briganti, A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection | 1-gen-2014 | Passoni, Nm; Abdollah, F; Suardi, N; Gallina, A; Bianchi, M; Tutolo, M; Fossati, N; Gandaglia, G; Salonia, A; Freschi, M; Rigatti, P; Montorsi, F; Briganti, A | |
How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder | 1-gen-2019 | Palumbo, C.; Mistretta, F. A.; Knipper, S.; Pecoraro, A.; Tian, Z.; Shariat, S. F.; Saad, F.; Simeone, C.; Briganti, A.; Antonelli, A.; Karakiewicz, P. I. | |
Is partial nephrectomy safe and effective in the setting of frail comorbid patients affected by renal cell carcinoma? Insights from the RECORD 2 multicentre prospective study | 1-gen-2021 | Gontero, P.; Mari, A.; Marra, G.; Nazzani, S.; Allasia, M.; Antonelli, A.; Barale, M.; Brunocilla, E.; Capitanio, U.; Di Maida, F.; Gallioli, A.; Longo, N.; Montorsi, F.; Porpiglia, F.; Porreca, A.; Rocco, B.; Simeone, C.; Schiavina, R.; Tellini, R.; Terrone, C.; Villari, D.; Ficarra, V.; Carini, M.; Minervini, A. | |
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses | 1-gen-2015 | Larcher, A; Fossati, N; Mistretta, F; Lughezzani, G; Lista, G; Dell'Oglio, P; Abrate, A; Sun, M; Karakiewicz, P; Suardi, N; Lazzeri, M; Montorsi, F; Guazzoni, G; Buffi, N | |
Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: a phase II study with a 5-year follow-up | 1-gen-2005 | Berruti, Alfredo; Fara, E; Tucci, M; Tarabuzzi, R; Mosca, A; Terrone, C; Gorzegno, G; Fasolis, G; Tampellini, M; Porpiglia, F; DE STEFANIS, M; Fontana, D; Bertetto, O; Dogliotti, L. | |
Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study. | 1-gen-2012 | A., Antonelli; N., Arrighi; S., Corti; T., Zanotelli; A., Cozzoli; S. C., Cunico; Simeone, Claudio | |
Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification | 1-gen-2013 | Abdollah, F; Sun, M; Suardi, N; Gallina, A; Capitanio, U; Bianchi, M; Tutolo, M; Fossati, N; Castiglione, F; Freschi, M; Karakiewicz, P; Rigatti, P; Montorsi, F; Briganti, A | |
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. | 1-gen-2013 | Saini, A; Berruti, Alfredo; Cracco, C; Sguazzotti, E; Porpiglia, F; Russo, L; Bertaglia, V; Picci, Rl; Negro, M; Tosco, A; Campagna, S; Scarpa, Rm; Dogliotti, L; Furlan, Pm; Ostacoli, L. | |
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. | 1-gen-2013 | Vigna-Taglianti, R; Russi, Eg; Boriano, A; Gianello, L; Denaro, N; Lucio, F; Arena, G; e Bastia M, Buglione Di Monale; Pergolizzi, S; Ricardi, U; Magrini, S. | |
The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: Conditional survival analysis | 1-gen-2014 | Abdollah, F; Suardi, N; Capitanio, U; Matloob, R; Fossati, N; Castiglione, F; Di Trapani, E; Di Trapani, D; Russo, A; Carenzi, C; Montorsi, F; Rigatti, P; Bertini, R | |
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset | 1-gen-2020 | Veccia, A.; Antonelli, A.; Minervini, A.; Mottrie, A.; Dell'Oglio, P.; Ashrafi, A. N.; Larcher, A.; Eun, D.; Bradshaw, A.; Amparore, D.; Brassetti, A.; Hampton, L. J.; Simeone, C.; Mari, A.; Carini, M.; De Naeyer, G.; Yang, K.; Capitanio, U.; Simone, G.; Porpiglia, F.; Derweesh, I.; Aron, M.; Autorino, R. | |
Utility of [C-11]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series | 1-gen-2014 | Passoni, Nm; Suardi, N; Abdollah, F; Picchio, M; Giovacchini, G; Messa, C; Freschi, M; Montorsi, F; Briganti, A | |
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series | 1-gen-2015 | Gandaglia, G; Ploussard, G; Isbarn, H; Suardi, N; De Visschere, Pjl; Futterer, Jj; Ghadjar, P; Massard, C; Ost, P; Sooriakumaran, P; Surcel, Ci; van den Bergh, Rcn; Montorsi, F; Ficarra, V; Giannarini, G; Briganti, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile